Journals / The anatolian journal of family medicine (Online) / 2020 / Cilt: 3 - Sayı: 1

Investigation into Parvovirus B19 Antibodies in Serum Samples Sent with Pre-diagnosis of Arthritis-Arthralgia

Pages
40–44
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As the parvovirus B19 seropositivity ratewas found high when compared to the general population studies, latent parvovirus B19 infection should beinvestigated in synovial tissue in patients with chronical arthritis and arthralgia complaints.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Parvovirus B19 belonging to the Erythrovirus genus is a single-stranded DNA virus in the familyParvoviridae.
📊
Key Findings & Data:The present study aims to determine parvovirus B19 seropositivity in serum samples sent withpre-diagnosis of arthritis/arthralgia and to evaluate the age dispersion retrospectively.Methods: Sixty-one patients with pre-diagnosis of arthritis/arthralgia were included in this study.
💡
Conclusion & Impact:As the parvovirus B19 seropositivity ratewas found high when compared to the general population studies, latent parvovirus B19 infection should beinvestigated in synovial tissue in patients with chronical arthritis and arthralgia complaints.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Parvovirus B19 belonging to the Erythrovirus genus is a single-stranded DNA virus in the familyParvoviridae. The present study aims to determine parvovirus B19 seropositivity in serum samples sent withpre-diagnosis of arthritis/arthralgia and to evaluate the age dispersion retrospectively.Methods: Sixty-one patients with pre-diagnosis of arthritis/arthralgia were included in this study. The patients’age ranged from 8 to 85 years old. In serum samples of the patients, parvovirus B19 IgM and IgG tests wereinvestigated using the enzyme immunoassay method.Results: The mean age of the patients was 45.2±17.8 years. Parvovirus B19 IgG and IgM positivity rates were40 (65.6%) and 2 (3.3%), respectively. Parvovirus B19 IgG positivity was highest at the ages over 50 years andlowest at the ages under 30 years (p=0.362). Parvovirus B19 IgG seropositivity was the highest in females witha rate of 72.0% (p=0.241).Conclusion: As a result, parvovirus B19 IgG and IgM positivity rates in the patient group with pre-diagnosis ofarthritis/arthralgia were 65.6% and 3.3%, respectively, in our study. As the parvovirus B19 seropositivity ratewas found high when compared to the general population studies, latent parvovirus B19 infection should beinvestigated in synovial tissue in patients with chronical arthritis and arthralgia complaints.

🔖

Cite This Article

ALBAYRAK, H., BAKIR, A., GÜNEY, M., YAVUZ, M. (2020). Investigation into Parvovirus B19 Antibodies in Serum Samples Sent with Pre-diagnosis of Arthritis-Arthralgia. The anatolian journal of family medicine (Online), Cilt: 3 - Sayı: 1, 40–44. https://ajindex.com/articles/365007

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Young NS, Brown KE. Parvovirus B19. N Engl J Med 2004;350(6):586–97
  2. Corcoran A, Doyle S. Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19. J Med Microbiol 2004;53(Pt 6):459–75
  3. Tolfvenstam T, Broliden K. Parvovirus B19 infection. Semin Fetal Neonatal Med 2009;14(4):218–21
  4. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001;5(5):320–30
  5. Anderson LJ, Tsou C, Parker RA, Chorba TL, Wulff H, Tattersall P, et al. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay. J Clin Microbiol 1986;24(4):522–6
  6. Colmegna I, Alberts-Grill N. Parvovirus B19: its role in chronic arthritis. Rheum Dis Clin North Am 2009;35(1):95–110
  7. Anderson M, Cohen B, Schwarz T, Roggendorf M, Deinhardt F. Human parvovirus B19 infections in United Kingdom 1984- 86. Lancet 1987;1(8535):738–9
  8. Gilbert NL, Gyorkos TW, Béliveau C, Rahme E, Muecke C, Soto JC. Seroprevalence of parvovirus B19 infection in daycare educators. Epidemiol Infect 2005;133(2):299–304
  9. Kerr JR. A review of blood diseases and cytopenias associated with human parvovirus B19 infection. Rev Med Virol 2015;25(4):224–40
  10. Heegaard ED, Brown KE. Human parvovirus B19. Clin Microbiol Rev 2002;15(3):485–505
  11. Kerr JR. Pathogenesis of human parvovirus B19 in rheumatic disease. Ann Rheum Dis 2000;59(9):672–83
  12. Vassilopoulos D, Calabrese LH. Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 2008;10(5):215
  13. Beigi RH, Wiesenfeld HC, Landers DV, Simhan HN. High rate of severe fetal outcomes associated with maternal parvovirus b19 infection in pregnancy. Infect Dis Obstet Gynecol 2008;2008:524601
  14. Jensen IP, Thorsen P, Jeune B, Møller BR, Vestergaard BF. An epidemic of parvovirus B19 in a population of 3,596 pregnant women: a study of sociodemographic and medical risk factors. BJOG 2000;107(5):637–43
  15. Caliskan R, Masatlioglu S, Aslan M, Altun S, Saribas S, Ergin S, et al. The relationship between arthritis and human parvovirus B19 infection. Rheumatol Int 2005;26(1):7–11
  16. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000;12(4):289–94
  17. Ogawa E, Otaguro S, Murata M, Kainuma M, Sawayama Y, Furusyo N, et al. Intravenous immunoglobulin therapy for severe arthritis associated with human parvovirus B19 infection. J Infect Chemother 2008;14(5):377–82
  18. Stahl HD